Educational Areas/Call for Grants
| Areas of Educational Interest | Available Funding | Call for Grants |
|---|---|---|
| Cardiovascular | ||
| Acute Coronary Syndrome |  |
|
| Coagulation Therapy | |
|
| High Risk Prior Myocardial Infarction |  |
|
| Hypertriglyceridemia |   |
|
| Heart Failure – SGLT2 Inhibition | |
|
| Secondary Prevention Acute Ischemic Stroke | |
|
| INFECTIONS & VACCINES | ||
| SARS-CoV-2 Monoclonal Antibodies | |
|
| SARS-CoV-2 Vaccine | |
|
| Nephrology | ||
| Chronic Kidney Disease - Anemia | |
|
| Chronic Kidney Disease – SGLT2 Inhibition | |
|
| Hyperkalemia | |
CGA Nephrology Hyperkalemia 2022 |
| Oncology | ||
| Advanced Breast Cancer | ||
| BRCA | |
CGA Oncology Breast Cancer BRCA 2022 |
| Non-BRCA | |
|
| DNA Damage Response | |
|
| PARP Inhibition | |
|
| HER2+ | |
CGA ONC Breast Cancer HER2 2022 Pathology |
| Metastatic HR+ | |
|
| Cervical Cancer | ||
| Locally Advanced Cervical Cancer (LACC) | |
|
| Gastric Cancer | ||
| Gastric Cancer - HER2+ | |
|
| Hematology | ||
| CLL (Chronic Lymphocytic Leukemia) | |
|
| MCL (Mantle Cell Lymphoma) | |
|
| DLBCL (Diffuse Large B-Cell Lymphoma) | |
|
| Immuno-Oncology | ||
| Biliary Track Cancer (BTC) | |
|
| Bladder Cancer | |
|
| Endometrial Cancer | |
|
| HCC (Hepatocellular Carcinoma) |
|
|
| Non-Small Cell Lung Cancer (NSCLC) | |
|
| Small Cell Lung Cancer (SCLC) | |
|
| Neurofibromatosis | ||
| Neurofibromatosis Type 1 | |
|
| Plexiform Neurofibromas | |
|
| Non-Small Cell Lung Cancer | ||
| EGFR Diagnostics & Plasma Testing | |
|
| EGFRm NSCLC | |
|
| HER2+ NSCLC | |
|
| TROP2 NSCLC | |
|
| Ovarian Cancer | ||
| BRCA | |
|
| Non-BRCA | |
|
| PARP Inhibition | |
|
| DNA Damage Response | |
|
| Pancreatic Cancer | ||
| BRCA | |
|
| DNA Damage Response | |
|
| PARP Inhibition | |
|
| Prostate Cancer (mCRPC) | ||
| DNA Damage Response | |
|
| Homologus Recombination Repair | |
|
| PARP Inhibition | |
|
| Respiratory | ||
| Asthma (EX-US only) | |
|
| Chronic Cough (EX-US only) | |
|
| COPD | |
|
| CRSwNP (limited budget) | |
|
| Eosinophilic Esophagitis (limited budget) | |
|
| Severe Asthma (CGAs for US Only) | |
|
| Rheumatology/Immunology/Autoimmune | ||
| Systemic Lupus Erythematosus (limited budget) |
|
|
| R & D Discovery | ||
| Scientific or educational activities designed to educate research scientists, principal researchers, drug development professionals, academics, pre-doctoral students, doctoral students and fellows. These programs must be educational and non-promotional in nature and planned, designed and implemented in accordance with the U.S. Food and Drug Administration's Guidance on Industry-Supported Scientific and Educational Activities. | |
|